Current guidelines recommend transdermal delivery of testosterone for post-menopausal women seeking treatment for hypoactive sexual desire disorder. Medherant’s TEPI patch has been developed to fill ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback